Connecting systemic inflammation to prognosis in neuroendocrine neoplasms: a biomarker-based approach
Authors
Loading...
Retrospective analysis connects inflammatory biomarkers with mortality in neuroendocrine neoplasms, suggesting improved risk assessment.
Ilieșiu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: